Get startedLog in
    Picture of Stayble Therapeutics AB logo

    STABL — Stayble Therapeutics AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Stayble Therapeutics To Report STA363 Study Results During H2 2022

    Picture of Stayble Therapeutics AB logoStayble Therapeutics AB
    21/04/2021 12:32
    April 21 (Reuters) - Stayble Therapeutics AB  STABL.ST :
    * TO REPORT STA363 STUDY RESULTS DURING H2 2022

Source text for Eikon:  ID:nWkr86lj8L 
Further company coverage:  STABL.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 587696600;))

    Recent news on Stayble Therapeutics AB

    See all news